NCT03217968View on ClinicalTrials.gov

Abortive Treatment of Migraine With the Cefaly® Abortive Program Device

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

January 10, 2018

Study Completion Date

January 10, 2018

Conditions
Migraine
Interventions
DEVICE

Cefaly® Abortive Program device

The Cefaly® Abortive Program device is an external cranial neurostimulator designed for supraorbital neurostimulation, also known as external Trigeminal Nerve Stimulation (e-TNS).

Trial Locations (1)

14609

Rochester Clinical Research, Inc., Rochester

Sponsors

Lead Sponsor

Cefaly Technology
All Listed Sponsors
lead

Cefaly Technology

INDUSTRY

NCT03217968 - Abortive Treatment of Migraine With the Cefaly® Abortive Program Device | Biotech Hunter | Biotech Hunter